LOAME
REGN icon

Lombard Odier Asset Management (Europe)’s Regeneron Pharmaceuticals REGN Stock Holding History

Lombard Odier Asset Management (Europe)’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.8M Sell
17,875
-3,124
-15% -$2.39M 0.75% 46
2025
Q4 		$16.2M Buy
+20,999
New +$14.3M 0.8% 35
2024
Q3 		– Sell
-1,690
Closed -$1.78M – 297
2024
Q2 		$1.78M Buy
+1,690
New +$1.64M 0.08% 209
2023
Q2 		– Sell
-1,530
Closed -$1.26M – 285
2023
Q1 		$1.26M Sell
1,530
-148
-9% -$112K 0.06% 218
2022
Q4 		$1.21M Buy
+1,678
New +$1.24M 0.05% 232
2020
Q4 		– Sell
-797
Closed -$446K – 349
2020
Q3 		$446K Buy
+797
New +$483K 0.03% 198
2020
Q2 		– Sell
-882
Closed -$431K – 257
2020
Q1 		$431K Hold
882
– – 0.03% 175
2019
Q4 		$331K Hold
882
– – 0.02% 272
2019
Q3 		$245K Hold
882
– – 0.02% 328
2019
Q2 		$276K Hold
882
– – 0.02% 308
2019
Q1 		$362K Hold
882
– – 0.04% 222
2018
Q4 		$329K Hold
882
– – 0.03% 238
2018
Q3 		$356K Hold
882
– – 0.02% 263
2018
Q2 		$304K Buy
882
+120
+16% +$37.5K 0.02% 273
2018
Q1 		$262K Sell
762
-106
-12% -$36.9K 0.02% 296
2017
Q4 		$326K Sell
868
-87
-9% -$35.2K 0.02% 278
2017
Q3 		$427K Hold
955
– – 0.02% 258
2017
Q2 		$469K Hold
955
– – 0.03% 228
2017
Q1 		$370K Hold
955
– – 0.02% 239
2016
Q4 		$351K Hold
955
– – 0.13% 214
2016
Q3 		$384K Hold
955
– – 0.13% 196
2016
Q2 		$334K Buy
+955
New +$368K 0.02% 257
2015
Q1 		– Sell
-1,424
Closed -$587K – 136
2014
Q4 		$587K Buy
+1,424
New +$560K 0.13% 101

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Lombard Odier Asset Management (Europe)'s REGN Position: Q1 2026 in Review

Lombard Odier Asset Management (Europe) reduced its Regeneron Pharmaceuticals (REGN) stake by 15% in Q1 2026, selling an estimated $2.39M and leaving 17,875 shares worth $13.8M. The position accounts for 0.75% of the portfolio, ranked #46.

Lombard Odier Asset Management (Europe) first reported a position in REGN in Q4 2014 and has held it in 23 quarters since. The position peaked at $16.2M in Q4 2025. 1,396 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • Lombard Odier Asset Management (Europe) held 17,875 shares of Regeneron Pharmaceuticals worth $13.8M as of Q1 2026.
  • Lombard Odier Asset Management (Europe) sold 3,124 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $2.39M.
  • Regeneron Pharmaceuticals made up 0.75% of Lombard Odier Asset Management (Europe)'s portfolio in Q1 2026, its #46 holding.
  • Lombard Odier Asset Management (Europe) first reported a position in Regeneron Pharmaceuticals in Q4 2014 and has held it in 23 quarters since.
  • Lombard Odier Asset Management (Europe)'s Regeneron Pharmaceuticals position peaked at $16.2M in Q4 2025.
  • 1,396 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Lombard Odier Asset Management (Europe)'s 13F filing for Q1 2026, filed 15 May 2026.